Drug Type Small molecule drug, Monoclonal antibody |
Synonyms |
Target |
Mechanism APCS inhibitors(Serum amyloid P-component inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H24N2O6 |
InChIKeyHZLAWYIBLZNRFZ-VXGBXAGGSA-N |
CAS Registry224624-80-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyloidosis | Phase 2 | - | - | |
Amyloidosis | Phase 2 | - | - |